Garvan keeps prize to itself
Thursday, 16 October, 2008
The Garvan Institute’s Dr Alex Viardot has been awarded the inaugural GlaxoSmithKline Don Chisholm Diabetes Research Fellowship.
The fellowship, worth $90,000 a year for two years, is aimed at assisting research into type 2 diabetes and is named in honour of renowned endocrinologist and diabetes researcher Professor Don Chisholm.
Chisholm was the founder of the diabetes centre at St Vincent’s Hospital in Sydney in 1980 and a senior principal research fellow at the Garvan’s diabetes and obesity research program. He specialises in insulin resistance and its relationship to abdominal fat.
Viardot has been working as a postgraduate research fellow with the Garvan’s diabetes program since 2004. Originally from Germany, he is investigating immune system activation in pre-diabetes and in type 2 diabetes, focusing on hormonal modulation of the immune function by insulin.
He is also investigating novel predictors of type 2 diabetes in people with a family history.
GSK’s medical advisor, Dr Eugene Goh, said the idea behind the fellowship was not only to contribute to basic research into the diabetes epidemic, but also to honour Chisholm and recognise his contribution to diabetes from both a clinical and research perspective.
Anti-inflammatory drug may help treat alcohol use disorder
A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...
Osteoarthritis study uncovers new genetic links, drug targets
The genome-wide association study (GWAS) uncovered over 900 genetic associations, more than 500...
How brain cells are affected by Tourette syndrome
US researchers have conducted a cell-by-cell analysis of brain tissue from individuals with...
